{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:28:25Z","timestamp":1776821305864,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82200687"],"award-info":[{"award-number":["82200687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82170623"],"award-info":[{"award-number":["82170623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82170625"],"award-info":[{"award-number":["82170625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82322011"],"award-info":[{"award-number":["82322011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82241054"],"award-info":[{"award-number":["82241054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82000613"],"award-info":[{"award-number":["82000613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82000574"],"award-info":[{"award-number":["82000574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2017YFA0205404"],"award-info":[{"award-number":["2017YFA0205404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["24NSFSC0232"],"award-info":[{"award-number":["24NSFSC0232"]}]},{"name":"Sichuan Science and Technology Program","award":["21ZDYF1667"],"award-info":[{"award-number":["21ZDYF1667"]}]},{"name":"Sichuan Science and Technology Program","award":["2020YJ0084"],"award-info":[{"award-number":["2020YJ0084"]}]},{"name":"Sichuan Science and Technology Program","award":["2021YFS0147"],"award-info":[{"award-number":["2021YFS0147"]}]},{"name":"Sichuan Science and Technology Program","award":["2022NSFSC0819"],"award-info":[{"award-number":["2022NSFSC0819"]}]},{"name":"the 135 projects for disciplines of excellence of West China Hospital, Sichuan University","award":["ZYGD18004"],"award-info":[{"award-number":["ZYGD18004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00018-023-05032-y","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:02:25Z","timestamp":1701086545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Disruption of cholangiocyte-B cell crosstalk by blocking the CXCL12-CXCR4 axis alleviates liver fibrosis"],"prefix":"10.1007","volume":"80","author":[{"given":"Linhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-7867","authenticated-orcid":false,"given":"Jinhang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"5032_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gines","year":"2021","unstructured":"Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398:1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet"},{"key":"5032_CR2","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB (2020) Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol 18:2650\u20132666. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.060","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5032_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"TD Kisseleva","year":"2021","unstructured":"Kisseleva TD (2021) Brenner Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18:151\u2013166. https:\/\/doi.org\/10.1038\/s41575-020-00372-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5032_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL (2021) The power of plasticity-metabolic regulation of hepatic stellate cells. Cell Metab 33:242\u2013257. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.026","journal-title":"Cell Metab"},{"key":"5032_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"MM Parola","year":"2019","unstructured":"Parola MM, Pinzani. (2019) Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37\u201355. https:\/\/doi.org\/10.1016\/j.mam.2018.09.002","journal-title":"Mol Aspects Med"},{"key":"5032_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"SE Sutti","year":"2020","unstructured":"Sutti SE, Albano. (2020) Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol 17:81\u201392. https:\/\/doi.org\/10.1038\/s41575-019-0210-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5032_CR7","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/hep.29636","volume":"67","author":"F Faggioli","year":"2018","unstructured":"Faggioli F, Palagano E, Di Tommaso L, Donadon M, Marrella V, Recordati C, Mantero S, Villa A, Vezzoni P, Cassani B (2018) B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury. Hepatology 67:1970\u20131985. https:\/\/doi.org\/10.1002\/hep.29636","journal-title":"Hepatology"},{"key":"5032_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/hep.31755","volume":"74","author":"F Barrow","year":"2021","unstructured":"Barrow F, Khan S, Fredrickson G, Wang H, Dietsche K, Parthiban P, Robert S, Kaiser T, Winer S, Herman A, Adeyi O, Mouzaki M, Khoruts A, Hogquist KA, Staley C, Winer DA, Revelo XS (2021) Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling. Hepatology 74:704\u2013722. https:\/\/doi.org\/10.1002\/hep.31755","journal-title":"Hepatology"},{"key":"5032_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/1751-2980.12362","volume":"17","author":"F Zhang","year":"2016","unstructured":"Zhang F, Jiang WW, Li X, Qiu XY, Wu Z, Chi YJ, Cong X, Liu YL (2016) Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells. J Dig Dis 17:464\u2013474. https:\/\/doi.org\/10.1111\/1751-2980.12362","journal-title":"J Dig Dis"},{"key":"5032_CR10","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/hep.27761","volume":"61","author":"M Thapa","year":"2015","unstructured":"Thapa M, Chinnadurai R, Velazquez VM, Tedesco D, Elrod E, Han JH, Sharma P, Ibegbu C, Gewirtz A, Anania F, Pulendran B, Suthar MS, Grakoui A (2015) Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity. Hepatology 61:2067\u20132079. https:\/\/doi.org\/10.1002\/hep.27761","journal-title":"Hepatology"},{"key":"5032_CR11","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1172\/JCI24798","volume":"115","author":"TI Novobrantseva","year":"2005","unstructured":"Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S, Shlomchik MJ, Koteliansky V, Hochman PS, Ibraghimov A (2005) Attenuated liver fibrosis in the absence of B cells. J Clin Invest 115:3072\u20133082. https:\/\/doi.org\/10.1172\/JCI24798","journal-title":"J Clin Invest"},{"key":"5032_CR12","doi-asserted-by":"publisher","first-page":"729143","DOI":"10.3389\/fimmu.2021.729143","volume":"12","author":"AM Patel","year":"2021","unstructured":"Patel AM, Liu YS, Davies SP, Brown RM, Kelly DA, Scheel-Toellner D, Reynolds GM, Stamataki Z (2021) The Role of B Cells in Adult and Paediatric Liver Injury. Front Immunol 12:729143. https:\/\/doi.org\/10.3389\/fimmu.2021.729143","journal-title":"Front Immunol"},{"key":"5032_CR13","doi-asserted-by":"publisher","first-page":"e21260","DOI":"10.1096\/fj.202001273R","volume":"35","author":"C Britton","year":"2021","unstructured":"Britton C, Poznansky MC, Reeves P (2021) Polyfunctionality of the CXCR4\/CXCL12 axis in health and disease: implications for therapeutic interventions in cancer and immune-mediated diseases. FASEB J 35:e21260. https:\/\/doi.org\/10.1096\/fj.202001273R","journal-title":"FASEB J"},{"key":"5032_CR14","doi-asserted-by":"publisher","first-page":"578548","DOI":"10.3389\/fimmu.2021.578548","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen Z, Liu S, He C, Sun J, Wang L, Chen H, Zhang F (2021) CXCL12-CXCR4-mediated chemotaxis supports accumulation of mucosal-associated invariant T cells into the liver of patients with PBC. Front Immunol 12:578548. https:\/\/doi.org\/10.3389\/fimmu.2021.578548","journal-title":"Front Immunol"},{"key":"5032_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cyto.2019.02.006","volume":"117","author":"A Chalin","year":"2019","unstructured":"Chalin A, Lefevre B, Devisme C, Barget N, Amiot L, Samson M (2019) Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection. Cytokine 117:72\u201378. https:\/\/doi.org\/10.1016\/j.cyto.2019.02.006","journal-title":"Cytokine"},{"key":"5032_CR16","doi-asserted-by":"publisher","first-page":"e0151765","DOI":"10.1371\/journal.pone.0151765","volume":"11","author":"LN Chow","year":"2016","unstructured":"Chow LN, Schreiner P, Ng BY, Lo B, Hughes MR, Scott RW, Gusti V, Lecour S, Simonson E, Manisali I, Barta I, McNagny KM, Crawford J, Webb M, Underhill TM (2016) Impact of a CXCL12\/CXCR4 antagonist in bleomycin (BLM) induced pulmonary fibrosis and carbon tetrachloride (CCl4) induced hepatic fibrosis in mice. PLoS ONE 11:e0151765. https:\/\/doi.org\/10.1371\/journal.pone.0151765","journal-title":"PLoS ONE"},{"key":"5032_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/hepr.12411","volume":"45","author":"Y Saiman","year":"2015","unstructured":"Saiman Y, Jiao J, Fiel MI, Friedman SL, Aloman C, Bansal MB (2015) Inhibition of the CXCL12\/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury. Hepatol Res 45:794\u2013803. https:\/\/doi.org\/10.1111\/hepr.12411","journal-title":"Hepatol Res"},{"key":"5032_CR18","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1007\/s10620-012-2239-8","volume":"57","author":"A Tsuchiya","year":"2012","unstructured":"Tsuchiya A, Imai M, Kamimura H, Takamura M, Yamagiwa S, Sugiyama T, Nomoto M, Heike T, Nagasawa T, Nakahata T, Aoyagi Y (2012) Increased susceptibility to severe chronic liver damage in CXCR4 conditional knock-out mice. Dig Dis Sci 57:2892\u20132900. https:\/\/doi.org\/10.1007\/s10620-012-2239-8","journal-title":"Dig Dis Sci"},{"key":"5032_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.lab.0000067498.89585.06","volume":"83","author":"R Terada","year":"2003","unstructured":"Terada R, Yamamoto K, Hakoda T, Shimada N, Okano N, Baba N, Ninomiya Y, Gershwin ME, Shiratori Y (2003) Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 83:665\u2013672. https:\/\/doi.org\/10.1097\/01.lab.0000067498.89585.06","journal-title":"Lab Invest"},{"key":"5032_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/eji.200324441","volume":"34","author":"O Wald","year":"2004","unstructured":"Wald O, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, Franitza S, Weiss I, Avniel S, Boaz P, Hanna J, Zamir G, Eid A, Mandelboim O, Spengler U, Galun E, Peled A (2004) Involvement of the CXCL12\/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 34:1164\u20131174. https:\/\/doi.org\/10.1002\/eji.200324441","journal-title":"Eur J Immunol"},{"key":"5032_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10620-009-0757-9","volume":"55","author":"Y Lei","year":"2010","unstructured":"Lei Y, Liu Z, Han Q, Kang W, Zhang L, Lou S (2010) G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure. Dig Dis Sci 55:285\u2013291. https:\/\/doi.org\/10.1007\/s10620-009-0757-9","journal-title":"Dig Dis Sci"},{"key":"5032_CR22","doi-asserted-by":"publisher","first-page":"17762","DOI":"10.1038\/srep17762","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yang X, Jing Y, Zhang S, Zong C, Jiang J, Sun K, Li R, Gao L, Zhao X, Wu D, Shi Y, Han Z, Wei L (2015) Contribution and mobilization of mesenchymal stem cells in a mouse model of carbon tetrachloride-induced liver fibrosis. Sci Rep 5:17762. https:\/\/doi.org\/10.1038\/srep17762","journal-title":"Sci Rep"},{"key":"5032_CR23","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1111\/jcmm.16730","volume":"25","author":"L Zhang","year":"2021","unstructured":"Zhang L, Tai Y, Zhao C, Ma X, Tang S, Tong H, Tang C, Gao J (2021) Inhibition of cyclooxygenase-2 enhanced intestinal epithelial homeostasis via suppressing beta-catenin signalling pathway in experimental liver fibrosis. J Cell Mol Med 25:7993\u20138005. https:\/\/doi.org\/10.1111\/jcmm.16730","journal-title":"J Cell Mol Med"},{"key":"5032_CR24","doi-asserted-by":"publisher","first-page":"119203","DOI":"10.1016\/j.lfs.2021.119203","volume":"272","author":"S Tang","year":"2021","unstructured":"Tang S, Huang Z, Jiang J, Gao J, Zhao C, Tai Y, Ma X, Zhang L, Ye Y, Gan C, Su W, Jia X, Liu R, Wu H, Tang C (2021) Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci 272:119203. https:\/\/doi.org\/10.1016\/j.lfs.2021.119203","journal-title":"Life Sci"},{"key":"5032_CR25","doi-asserted-by":"publisher","first-page":"10389","DOI":"10.1111\/jcmm.16968","volume":"25","author":"Y Tai","year":"2021","unstructured":"Tai Y, Zhao C, Zhang L, Tang S, Jia X, Tong H, Liu R, Tang C, Gao J (2021) Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress. J Cell Mol Med 25:10389\u201310402. https:\/\/doi.org\/10.1111\/jcmm.16968","journal-title":"J Cell Mol Med"},{"key":"5032_CR26","doi-asserted-by":"publisher","first-page":"G962","DOI":"10.1152\/ajpgi.00428.2015","volume":"310","author":"JH Gao","year":"2016","unstructured":"Gao JH, Wen SL, Tong H, Wang CH, Yang WJ, Tang SH, Yan ZP, Tai Y, Ye C, Liu R, Huang ZY, Tang YM, Yang JH, Tang CW (2016) Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats. Am J Physiol Gastrointest Liver Physiol 310:G962\u2013G972. https:\/\/doi.org\/10.1152\/ajpgi.00428.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5032_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10456-016-9522-9","volume":"19","author":"JH Gao","year":"2016","unstructured":"Gao JH, Wen SL, Feng S, Yang WJ, Lu YY, Tong H, Liu R, Tang SH, Huang ZY, Tang YM, Yang JH, Xie HQ, Tang CW (2016) Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis 19:501\u2013511. https:\/\/doi.org\/10.1007\/s10456-016-9522-9","journal-title":"Angiogenesis"},{"key":"5032_CR28","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/s41598-018-24548-z","volume":"8","author":"F Al-Rashed","year":"2018","unstructured":"Al-Rashed F, Calay D, Lang M, Thornton CC, Bauer A, Kiprianos A, Haskard DO, Seneviratne A, Boyle JJ, Schonthal AH, Wheeler-Jones CP, Mason JC (2018) Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. Sci Rep 8:6271. https:\/\/doi.org\/10.1038\/s41598-018-24548-z","journal-title":"Sci Rep"},{"key":"5032_CR29","first-page":"1088","volume":"9","author":"XT Xu","year":"2017","unstructured":"Xu XT, Hu WT, Zhou JY, Tu Y (2017) Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP. Am J Transl Res 9:1088\u20131100","journal-title":"Am J Transl Res"},{"key":"5032_CR30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3892\/ijo.2015.2820","volume":"46","author":"D Tamura","year":"2015","unstructured":"Tamura D, Saito T, Murata K, Kawashima M, Asano R (2015) Celecoxib exerts antitumor effects in canine mammary tumor cells via COX2independent mechanisms. Int J Oncol 46:1393\u20131404. https:\/\/doi.org\/10.3892\/ijo.2015.2820","journal-title":"Int J Oncol"},{"key":"5032_CR31","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1158\/1078-0432.CCR-13-2305","volume":"20","author":"AS Gallouet","year":"2014","unstructured":"Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K, Guillaudeux T (2014) COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Clin Cancer Res 20:2663\u20132673. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2305","journal-title":"Clin Cancer Res"},{"key":"5032_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-023-00284-4","volume":"43","author":"T Lan","year":"2023","unstructured":"Lan T, Tai Y, Zhao C, Xiao Y, Yang Z, Zhang L, Gan C, Dai W, Tong H, Tang C, Huang Z, Gao J (2023) Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration. Inflamm Regen 43:37. https:\/\/doi.org\/10.1186\/s41232-023-00284-4","journal-title":"Inflamm Regen"},{"key":"5032_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke I, Dapito DH, Affo S, Uchinami H, Schwabe RF (2015) High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc 10:305\u2013315. https:\/\/doi.org\/10.1038\/nprot.2015.017","journal-title":"Nat Protoc"},{"key":"5032_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071049","author":"CN Sobolewski","year":"2021","unstructured":"Sobolewski CN, Legrand. (2021) Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules. https:\/\/doi.org\/10.3390\/biom11071049","journal-title":"Biomolecules"},{"key":"5032_CR35","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.3390\/jcm10163496","volume":"10","author":"D Fuster","year":"2021","unstructured":"Fuster D, Garcia-Calvo X, Farre O, Zuluaga P, Bolao F, Leis A, Hernandez-Rubio A, Rivas I, Muga R (2021) Markers of monocyte activation, inflammation, and microbial translocation are associated with liver fibrosis in alcohol use disorder. J Clin Med 10:3496. https:\/\/doi.org\/10.3390\/jcm10163496","journal-title":"J Clin Med"},{"key":"5032_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249474","author":"X Chen","year":"2020","unstructured":"Chen X, Liu X, Duan S, Tang R, Zhou S, Ye R, Yang Y, Wang J, Yao S, He N (2020) Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph17249474","journal-title":"Int J Environ Res Public Health"},{"key":"5032_CR37","doi-asserted-by":"publisher","first-page":"827254","DOI":"10.1155\/2013\/827254","volume":"2013","author":"GJ Tobon","year":"2013","unstructured":"Tobon GJ, Izquierdo JH, Canas CA (2013) B lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus. Autoimmune Dis 2013:827254. https:\/\/doi.org\/10.1155\/2013\/827254","journal-title":"Autoimmune Dis"},{"key":"5032_CR38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/cyto.10032","volume":"46","author":"AX Hendrickx","year":"2001","unstructured":"Hendrickx AX, Bossuyt. (2001) Quantification of the leukocyte common antigen (CD45) in mature B-cell malignancies. Cytometry 46:336\u2013339. https:\/\/doi.org\/10.1002\/cyto.10032","journal-title":"Cytometry"},{"key":"5032_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.ai.2016.07.002","volume":"132","author":"K Kajikhina","year":"2016","unstructured":"Kajikhina K, Tsuneto M, Melchers F (2016) B-lymphopoiesis in fetal liver, guided by chemokines. Adv Immunol 132:71\u201389. https:\/\/doi.org\/10.1016\/bs.ai.2016.07.002","journal-title":"Adv Immunol"},{"key":"5032_CR40","doi-asserted-by":"publisher","first-page":"G203","DOI":"10.1152\/ajpgi.00193.2016","volume":"311","author":"AF Liepelt","year":"2016","unstructured":"Liepelt AF, Tacke. (2016) Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases. Am J Physiol Gastrointest Liver Physiol 311:G203\u2013G209. https:\/\/doi.org\/10.1152\/ajpgi.00193.2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5032_CR41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000205388","volume":"76","author":"MS Pino","year":"2009","unstructured":"Pino MS, Milella M, Gelibter A, Sperduti I, De Marco S, Nuzzo C, Bria E, Carpanese L, Ruggeri EM, Carlini P, Cognetti F (2009) Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. Oncology 76:254\u2013261. https:\/\/doi.org\/10.1159\/000205388","journal-title":"Oncology"},{"key":"5032_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00418-011-0889-9","volume":"137","author":"M Wojcik","year":"2012","unstructured":"Wojcik M, Ramadori P, Blaschke M, Sultan S, Khan S, Malik IA, Naz N, Martius G, Ramadori G, Schultze FC (2012) Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol 137:217\u2013233. https:\/\/doi.org\/10.1007\/s00418-011-0889-9","journal-title":"Histochem Cell Biol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05032-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:16:12Z","timestamp":1702998972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5032"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05032-y","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"31 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animals received human care and study protocols complied with the guidelines of and were approved by Animal Use and Care Committee of West China Hospital, Sichuan University (No. 2021741A). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the the Ethical Committee of West China Hospital (No. 2022989).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"379"}}